[PLX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 54.02%
YoY- 77.10%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 10,967 21,646 17,759 14,248 12,247 10,439 27,018 -45.20%
PBT -4,150 1,667 291 -3,560 -7,743 -7,264 9,781 -
Tax 38 203 180 34 3 190 99 -47.21%
NP -4,150 1,667 291 -3,560 -7,743 -7,264 9,781 -
Tax Rate - -12.18% -61.86% - - - -1.01% -
Total Cost 15,117 19,979 17,468 17,808 19,990 17,703 17,237 -8.38%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -37.84 7.70 1.64 -24.99 -63.22 -69.59 36.20 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.13 0.10 0.02 -0.24 -0.52 -0.49 0.66 -
EPS Diluted -0.13 0.10 0.02 -0.24 -0.52 -0.49 0.66 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.